NCT01519518View on ClinicalTrials.gov

How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

1,829

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Acute ST Elevation Myocardial Infarction
Interventions
DRUG

unfractionated heparin

70 units/kg body weight intravenous

DRUG

Bivalirudin

intravenous bolus of 0.75 mg/kg followed by infusion of 1.75 mg/kg per hour

Trial Locations (1)

L14 3PE

Liverpool Heart and Chest Hospital, Liverpool

All Listed Sponsors
lead

Liverpool Heart and Chest Hospital NHS Foundation Trust

OTHER

NCT01519518 - How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter